Erythromycin ethyl succinate 250mg/5ml oral suspension
BNF presentation 0501050H0AAABAB within chapter Infections. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0501050H0AAABAB
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
14,353
NHS spend (£)
£206,255.18
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 2,015 |
| February 2025 | 14 |
| December 2024 | 792 |
| November 2024 | 2,608 |
| October 2024 | 2,417 |
| September 2024 | 4 |
| August 2024 | 138 |
| July 2024 | 2,737 |
| May 2024 | 919 |
| July 2021 | 617 |
| June 2021 | 393 |
| December 2020 | 748 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 91 | No data available |
| Unknown pharmacy | 79 | No data available |
| Unknown pharmacy | 59 | No data available |
| Unknown pharmacy | 54 | No data available |
| Unknown pharmacy | 52 | No data available |
| Unknown pharmacy | 46 | No data available |
| Unknown pharmacy | 41 | No data available |
| Unknown pharmacy | 37 | No data available |
| Unknown pharmacy | 36 | No data available |
| Unknown pharmacy | 33 | No data available |